Your browser doesn't support javascript.
loading
Provider perspectives and recommendations on standardized sexual function screening intervention in adolescent/young adult oncology patients.
Demedis, Jenna; Reedy, Julia; Chow, Eric J; Dorsey Holliman, Brooke; Peterson, Pamela N; Studts, Christina R.
Afiliação
  • Demedis J; Adult & Child Center for Health Outcomes Research & Delivery Science (ACCORDS), University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Reedy J; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Chow EJ; Center for Cancer and Blood Disorders at Children's Hospital Colorado, Aurora, Colorado, USA.
  • Dorsey Holliman B; Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Washington, USA.
  • Peterson PN; Center for Cancer and Blood Disorders at Children's Hospital Colorado, Aurora, Colorado, USA.
  • Studts CR; Department of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Pediatr Blood Cancer ; 71(4): e30872, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38233999
ABSTRACT

BACKGROUND:

Sexual function (SF) concerns are common among adolescent and young adult (AYA) cancer survivors, are underrecognized and undertreated. This study sought AYA oncology provider input on the implementation of an SF screening tool to address this unmet need. PROCEDURE Semi-structured interviews were completed with oncology providers (n = 25) who care for AYAs at a single institution. Interviews sought to understand barriers to addressing SF, elicit perspectives on use of an established screening tool, and obtain recommendations for SF screening intervention development and implementation. Interviews were developed using the Consolidated Framework for Implementation Research (CFIR); thematic analysis-guided interpretation.

RESULTS:

AYA oncology providers were in favor of using an SF screening tool, but confirmed previously identified barriers and implementation considerations within multiple CFIR domains, including concerns about privacy, patient comfort, provider buy-in, provider knowledge, resource needs, and workflow/capacity constraints. They identified numerous strategies to address barriers through screening intervention design and implementation approaches. For example, provider buy-in could be optimized through education, availability of clinical resources, creation of a dedicated sexual healthcare team, provider engagement in intervention development, and leadership involvement.

CONCLUSIONS:

Development and implementation of an effective SF screening intervention is necessary to improve diagnosis and treatment of sexual dysfunction, with the ultimate goal of improving sexual health-related quality of life in AYA cancer survivors. AYA oncology providers identified numerous intervention and implementation design strategies for the development and implementation of an SF screening intervention, which must be integrated with patient recommendations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Aspecto: Patient_preference Limite: Adolescent / Adult / Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Aspecto: Patient_preference Limite: Adolescent / Adult / Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos